Estimation of influence of loop diuretics with different elimination period on sodium retention
- Авторлар: Arutyunov G.P1, Dragunov D.O1, Sokolova A.V1
-
Мекемелер:
- Шығарылым: № 5 (2013)
- Беттер: 8-12
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261780
- ID: 261780
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Aim. Estimation of influence of peack natriuresis on sodium reabsorbtion enchancement and it's association with urinary excretion of Tamm-Horsfal protein (ТНР). Methods. 28 patients (mean age 47 ± 7,5 years) were included into the study. All patients were randomized to torasemide SR (n = і4) and torasemide IR (n = і4). Sodium excretion was determined in 8 urinary portions, collected every 3 hours during 24 hours; urinary excretion of THP was also analyzed. Questionnarie «Charlton: Salt Screener» was used for determination of salt intake. Results. Area under curve (AUC) of torasemide SR and torasemide IR did not differ significantly, but torasemide SR induced more prolonged diuresis. During 06.00-09.00 no differences in torasemide SR and torasemide IR-induced sodium reabsorbtion were observed, in 09.00—і2.00 interval sodium reabsorbtion demostrated peack of diuretic efficacy, in і2.00—і5.00 sodium reabsorbtion was enchanced in patients on torasemide IR. Sodium reabsorbtion restoration was seen in 24.00-03.00. Peack of urinary ТНР concentration was seen in period of maximum sodium retention. Conclusion. Torasemide SR is characterized by more prolonged elimination period, prolonged natriuresis and absence of sodium retenstion and elevation of Tamm-Horsfal protein.
Негізгі сөздер
Толық мәтін
Әдебиет тізімі
- Арутюнов Г.П., Оганезова Л.Г., Драгунов Д.О. Взаимосвязь периода полувыведения петлевого диуретика, выраженности натрийуреза и показателей центральной гемодинамики у больных ХСН (пилотное исследование) //ЖСН. - 2012; 13, 4(72): 222-227.
- Rosón M.I., Cavallero S. et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats// Kidney International. — 2006; 70:1439-1447.
- Charlton K.E., Steyn K, Levitt N.S. et al. Development and validation of a short questionnaire to assess sodium intake//Public Health Nutrition. — 2008; 11(01):83—94.
- Bates J., Raff H., Prasadan K. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication // Kidney Int. — 2004;65:791-797.
- Mutig K., Kahl T., Saritas T. Activation of the Bumetanide-sensitive Na+, K+, 2Cl- Cotransporter (NKCC2) Is Facilitated by Tamm-Horsfall Protein in a Chloride-sensitive Manner // The Journal of Biological Chemistry. -2011; 286(34):30200-30210.
- Barbanoj M.J., Ballester M.R. et al. A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation // Clin Exp Pharmacol Physiol. - 2009;36(5-6):469-477.
- Barbanoj M.J., Ballester M.R. et al. Comparison of repeated-dose pharmacokinetics of prolonged-release and immediate-release torasemide formulations in healthy young volunteers // FundamClinPharmacol. -2009;23(1):115-125.
- Gnanaraj J.F., Stephanvon H. The relevance of congestionin the cardio-renal syndrome //Kidney International. - 2013;83:384-391.
- Shayman J.A. Renal Patophysiology/Пер. с англ, 2-е изд. - СПб.: БИНОМ. «Невский Диалект», 1999:107.
- Tamm I., Horsfall F.L. Characterization and separation of an inhibitor of viral hemagglutination present in urine // Proc Soc Exp Biol Med. - 1950; 74:108-114.
- Зверев Я.Ф., ЖариковА.Ю., Брюханов В.М. и др. Модуляторы оксалатного нефролитиаза. Ингибиторы кристаллизации // Нефрология. -2010; 1(14):29-49.
- Hebert S.C. Barttersyndrome//Curr Opin NephrolHypertens. - 2003;12:527-532.
- Scolari F., Caridi G., Rampoldi L. et al. Uromodulin storage diseases: clinical aspects and mechanisms// Am J Kidney Dis. - 2004;44: 987-999.
Қосымша файлдар
